This months late great engineer was actually a scientist and surgeon rather than an engineer. But his discoveries have shaped our world significantly and, as the world scrambles for a COVID-19 vaccine, are particularly worthy of note at the current time. Meet father of immunology Edward Jenner. Written by Nick Smith.
Towards the end of the 18th century an English doctor by the name of Edward Jenner conducted an experiment on an eight-year-old boy that was to change the world. The experiment had its critics. The clergy said that Jenners work was repulsive and ungodly, while satirical cartoons appeared showing humans sprouting cows heads. But the advantages of using cowpox pus to inoculate against smallpox the deadliest disease in human history soon became clear, and Jenners pioneering work in the field became the rock upon which the fight against smallpox and other infectious human diseases was built. While Jenner wasnt alone in realising that inoculation with cowpox provided immunity to smallpox, he was the first to publish proof of its efficacy and to develop a reliable vaccine. Today, the physician from Berkley in Gloucester is known throughout the world as the father of immunology. Napoleon called Jenner one of the greatest benefactors of mankind.
Born in the mid-18th century on 17th May 1749, Jenner came into a world of fundamental change, so much so that Britain was just about to adopt the new Gregorian calendar that corrected errors in the former Julian calendar. It was a time when British medical practice and education was undergoing a quiet revolution in which the old demarcation between the Oxbridge physicians and the more hands-on apothecaries was becoming blurred. It was a time when practical experimentation and hospital work came to be regarded as being on an equal footing with academic research. It was also at time when the smallpox virus was killing 400,000 people per year in Europe. In Britain alone smallpox accounted for the lives of ten percent of the population, with this figure doubling in urban areas where infection spread more easily.
MORE LATE GREAT ENGINEERS
By Jenners time variolation treatment of a disease with the same disease to create immunity to itself was the widespread method of addressing smallpox. While it had some impact on reducing the effect of the virus, especially among the wealthy, the process was fraught with risk, not least in that those inoculated with the disease became carriers and could infect those around them. It wasnt until Jenners cowpox-based vaccination became common practice by the end of the 19th century that any significant reduction in incidence in Europe and North America occur. Even then the disease remained largely unchecked in other parts of the world, notably Africa, well into the 20th century, before intensive containment measures and scientific surveillance eventually led to its formal eradication on 9th December 1979. Four decades on, smallpox remains, in the words of World Health Organization Director-General Tedros Adhanom Ghebreyesus, the only human disease ever eradicated.
The part Jenner was to play in this eradication could not necessarily be predicted from his conventional background. The eighth of nine children, his father was the vicar of Berkley, which meant that he was destined for a robust provincial education in both Wooton-under-Edge and Cirencester. By the age of 14 he had been inoculated against smallpox by variolation and he had left school, apprenticed to the surgeon Daniel Ludlow for seven years, and from whom he gained sufficient experience to become a surgeon himself. At the age of 21, Jenner undertook a further apprenticeship in surgery and anatomy at St Georges Hospital in London. It was at this time that Jenner fell under the influence of surgeon John Hunter, who offered the young doctor the characteristic Age of Enlightenment advice: dont think; try. With this presumably still ringing in his ears in 1773, at the age of 24, Jenner returned to his Gloucester home where he became a practicing doctor and surgeon.
Meanwhile, English physician John Frewster had discovered that prior infection with cowpox rendered a person immune to smallpox. Also, in the 1770s, at least five simultaneous investigations were underway in Europe and Britain testing cowpox vaccination on humans against smallpox. In Britain, during the 1774 smallpox epidemic, Dorset farmer Benjamin Jesty successfully vaccinated his wife and two children with cowpox, and it is thought that Jenner may have been aware of Jestys work. Where Jenner comes into the story is that he managed to tie up some of the unknowns in his own research.
It had long been common knowledge that milkmaids were somehow immune to smallpox due to their routine proximity to cows and cowpox. Jenners hypothesis was that the well-known folklore of milkmaid immunity stemmed from the pus in the blisters they received from the less dangerous cowpox. To test this, on 14th May 1796, Jenner inoculated James Phipps, the eight-year-old son of his gardener. Jenner got pus samples from cowpox blisters on the hands of milkmaid Sarah Nelmes who had caught the disease from a cow called Blossom. Phipps presented with fever, but no full-blown cowpox infection, and so Jenner went to the next step of challenging the boys supposed immunity with the variolous material (ie smallpox itself) that had to date been the standard basis of inoculation. As no disease followed, Phippss immunity to smallpox was challenged repeatedly. The significance of these procedures is that they made significant inroads into proving not just that cowpox could provide immunity to smallpox, but that the protective cowpox pus could be effectively inoculated from person to person and not just directly from cattle. Jenner coined the term vaccination that linguistically has its roots in the Latin adjective vaccinus, meaning of, or related to, cows.
Jenner pressed on with his research and in 1798 published a monograph entitled An Inquiry into the Causes and Effects of the Variol Vaccinn, which was followed in annual succession by three further papers developing his ideas on vaccination. But it was to be a long and difficult road to having the concept of vaccination accepted as an alternative to variolation as the standard for smallpox prevention, with the medical establishment dithering for decades over the idea. Eventually, some 17 years after Jenners death, the British government banned variolation and provided optional vaccination using cowpox free of charge under the Vaccination Act 1840. It would be a further 12 years before vaccination became compulsory. Despite not living to see the full effects of his work, Jenner knew enough of his success to reflect that, the joy I felt as the prospect before me of being the instrument destined to take away from the world one of its greatest calamities was so excessive that I found myself in a kind of reverie.
Although Jenner might have cashed in on his success, having been widely honoured for his pioneering role in the emerging field of immunology, his single-minded focus on his work on the understanding of vaccination and vaccines meant that his country medical practice fell into neglect and suffered financially. To ensure his research into vaccination could continue, in 1802 Jenners colleagues, with the support of King George III, petitioned the British government for a grant of 10,000 (approximately 1m today), which was followed five years later by a further 20,000 after the Royal college of Physicians had confirmed the widespread efficacy of vaccination. In 1803 he became president of the Jennerian Society established to promote vaccination to eradicate smallpox, and in 1805 he became a founding member of the Medical and Chirurgical Society, that was to become the Royal Society of Medicine. By 1821 such was his influence that he became physician to the new king George IV and mayor of his hometown of Berkeley, where he is buried having died of stroke in 1823.
Although the disease may have been eradicated, there remain two official samples of the virus known to cause smallpox kept in tightly controlled WHO-sanctioned government laboratories in the United States and Russia. Their existence periodically raises the ethical debate over whether they should be destroyed, with the current position of both countries being outlined by the former Secretary of the U.S. Department of Health and Human Services, Kathleen Sebelius, who says that the dangers of destroying the samples outweigh the minuscule risk attached to keeping them. Their destruction, she says, would be purely symbolic and could leave the world vulnerable should we ever need to conduct further scientific research into the virus.
Jenners legacy is best articulated in the opening sentences of a resolution by the World Health Assembly published on 8th May 1980 that declares solemnly that the world and its peoples have won freedom from smallpox, which was a most devastating disease sweeping in epidemic form through many countries since earliest time, leaving death, blindness and disfigurement in its wake
Follow this link:
Late great engineers: Edward Jenner | The Engineer The Engineer - The Engineer
- Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off - R&D World - April 27th, 2025 [April 27th, 2025]
- Dr. Sabine Ehrt Named Chair of the Department of Microbiology and Immunology at Weill Cornell Medicine - WCM Newsroom - April 19th, 2025 [April 19th, 2025]
- RayThera launches with $110 million to advance immunology pipeline - The Pharma Letter - April 10th, 2025 [April 10th, 2025]
- Celebrate Vaccines: The legacy of the tetanus vaccine - British Society for Immunology - April 10th, 2025 [April 10th, 2025]
- Another immunology biotech emerges as Hillstar takes flight with $67M - Endpoints News - March 30th, 2025 [March 30th, 2025]
- Alumnus discovers passion for immunology, teaching at Mercer - Mercer University - March 15th, 2025 [March 15th, 2025]
- The future of immunology - Johnson & Johnson - March 5th, 2025 [March 5th, 2025]
- Immunotherapys Sweet Future: Wrapping up AACR IO 2025 With Glyco-immunology - American Association for Cancer Research (AACR) - March 5th, 2025 [March 5th, 2025]
- J&J receives three CHMP recommendations for immunology and oncology indications - PMLiVE - March 5th, 2025 [March 5th, 2025]
- Greater Austin Allergy, Asthma & Immunology now open in the Shops at the Galleria - Community Impact - March 5th, 2025 [March 5th, 2025]
- As dengue spreads, researchers discover a clue to fighting the virus - La Jolla Institute for Immunology - February 25th, 2025 [February 25th, 2025]
- Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma and Immunology and World Allergy Organization Joint Congress - Business... - February 25th, 2025 [February 25th, 2025]
- PhD candidate Jesse Lehman receives Kirschstein Award to study immunology - UMass Medical School - February 25th, 2025 [February 25th, 2025]
- Cross-priming in cancer immunology and immunotherapy - Nature.com - February 3rd, 2025 [February 3rd, 2025]
- Sanofi Happy To Spend To Hit Immunology Top Spot - News & Insights - February 3rd, 2025 [February 3rd, 2025]
- The Converging Therapeutic Landscape of Oncology and Immunology: Accelerating Innovation in Biotech - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- VC Firm Foresite Capital Dishes on Biotech Innovation in China, Opportunities in Immunology - MedCity News - January 23rd, 2025 [January 23rd, 2025]
- Immunology - The Scientist - January 23rd, 2025 [January 23rd, 2025]
- Immunology Startup Ouro Sets Out With $120M for Drugs That Reset the Immune System - MedCity News - January 15th, 2025 [January 15th, 2025]
- Scipher Medicine and Atropos Health Partner to Accelerate Precision Medicine and Expand the Immunology Multimodal Network - Business Wire - December 23rd, 2024 [December 23rd, 2024]
- AbbVie to expand immunology pipeline with $200m Nimble Therapeutics acquisition - PMLiVE - December 23rd, 2024 [December 23rd, 2024]
- Sir Gustav Nossal Professor of Immunology to honour giant of Australian science - Walter and Eliza Hall Institute of Medical Research - December 9th, 2024 [December 9th, 2024]
- Research Assistant in Immunology - Surrey, United Kingdom job with UNIVERSITY OF SURREY | 384335 - Times Higher Education - November 28th, 2024 [November 28th, 2024]
- Reflecting on Pioneering organoids and 3D cell cultures for animal and human health - British Society for Immunology | - November 28th, 2024 [November 28th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire - November 20th, 2024 [November 20th, 2024]
- TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire - November 20th, 2024 [November 20th, 2024]
- Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today - November 20th, 2024 [November 20th, 2024]
- Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian - November 20th, 2024 [November 20th, 2024]
- Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of... - November 20th, 2024 [November 20th, 2024]
- What it's like in allergy and immunology: Shadowing Dr. Fraser - American Medical Association - November 12th, 2024 [November 12th, 2024]
- Dr. Naba Sharif Elected President of the New Jersey Allergy Asthma and Immunology Society - Newswire - November 12th, 2024 [November 12th, 2024]
- Department of Microbiology and Immunology Named a National Milestones Program - Stony Brook News - October 26th, 2024 [October 26th, 2024]
- Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting - businesswire.com - October 26th, 2024 [October 26th, 2024]
- Remembering immunology educator, researcher Tom McDonald, PhD - University of Nebraska Medical Center - October 13th, 2024 [October 13th, 2024]
- Systems immunology approaches to study T cells in health and disease - Nature.com - October 13th, 2024 [October 13th, 2024]
- Leading the charge to discover answers in immunology - The University of Arizona - October 2nd, 2024 [October 2nd, 2024]
- New mouse models offer valuable window into COVID-19 infection - La Jolla Institute for Immunology - October 2nd, 2024 [October 2nd, 2024]
- Wide-Moat AbbVie Poised for Growth, Driven by Innovation in Immunology Beyond Humira - Morningstar - October 2nd, 2024 [October 2nd, 2024]
- Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss - FiercePharma - September 23rd, 2024 [September 23rd, 2024]
- Huang Named Head Of Pathology And Immunology - Mirage News - September 15th, 2024 [September 15th, 2024]
- Huang named head of pathology & immunology - Washington University School of Medicine in St. Louis - September 15th, 2024 [September 15th, 2024]
- Apogee Therapeutics to Participate at the Stifel 2024 Immunology and Inflammation Summit - Yahoo Finance - September 15th, 2024 [September 15th, 2024]
- Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - StockTitan - September 15th, 2024 [September 15th, 2024]
- UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy - UCLA Newsroom - September 2nd, 2024 [September 2nd, 2024]
- Boosting vaccines for the elderly with 'hyperactivators' - Boston Children's Answers - Boston Children's Discoveries - June 27th, 2024 [June 27th, 2024]
- Immunologists Want You to Know These Dust Mite Allergy Facts - Yahoo Lifestyle UK - June 27th, 2024 [June 27th, 2024]
- How Ragon Institute's new building aids its mission Harvard Gazette - Harvard Gazette - June 27th, 2024 [June 27th, 2024]
- Insights into CRS and NPs: Visual and Bibliometric Analysis - Physician's Weekly - June 27th, 2024 [June 27th, 2024]
- Biogen joins immunology wave with $1.15 billion acquisition of HI-Bio - STAT - May 24th, 2024 [May 24th, 2024]
- Biogen Buys Desired Growth In Immunology With $1.15bn Hi-Bio Deal - Scrip - May 24th, 2024 [May 24th, 2024]
- Biogen Boosts Immunology Portfolio with $1.8 Billion Acquisition of HI-Bio - BioPharm International - May 24th, 2024 [May 24th, 2024]
- Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395 - Yahoo Finance - May 24th, 2024 [May 24th, 2024]
- Biogen to expand immunology and rare disease portfolio with $1.8bn HI-Bio acquisition - PMLiVE - May 24th, 2024 [May 24th, 2024]
- Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress - Business Wire - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in deal worth up to $1.8B - MM+M Online - May 24th, 2024 [May 24th, 2024]
- COVID-19 Re-Vaccinations Elicit Neutralizing Antibodies Against Future Variants - Technology Networks - May 24th, 2024 [May 24th, 2024]
- HIV Vaccine Candidate Induces Broadly Neutralizing Antibodies in Humans - Technology Networks - May 24th, 2024 [May 24th, 2024]
- Pasteur Fiocruz Center on Immunology and Immunotherapy is inaugurated in Cear - Fiocruz - May 24th, 2024 [May 24th, 2024]
- Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal - Marketscreener.com - May 24th, 2024 [May 24th, 2024]
- Fellow Focus in Four: Marat Kribis, MD, Rheumatology, Allergy and Immunology - Yale School of Medicine - April 15th, 2024 [April 15th, 2024]
- Long COVID Can Now Be Detected in the Blood - Technology Networks - April 15th, 2024 [April 15th, 2024]
- Rimjhim Agarwal selected as Major Symposium speaker at the American Association of Immunologists ... - La Jolla Institute for Immunology - March 29th, 2024 [March 29th, 2024]
- Seeking new horizons: Where innovators find opportunities in a fast-changing immunology landscape - IQVIA - March 29th, 2024 [March 29th, 2024]
- Researchers identify new way to inhibit immune cells that drive allergic asthma - EurekAlert - March 29th, 2024 [March 29th, 2024]
- Innovation in Oncology and Cancer Immunology Research - Boehringer Ingelheim - March 29th, 2024 [March 29th, 2024]
- Measles outbreaks show the risk of under-vaccination | News | Harvard T.H. Chan School of Public Health - HSPH News - March 29th, 2024 [March 29th, 2024]
- Immunology-oncology ELISA Kits Market to Witness a Healthy Growth by 2030 - WhaTech - March 29th, 2024 [March 29th, 2024]
- Spring Allergy Season Is Getting Worse. Here's What to Know. - The New York Times - March 29th, 2024 [March 29th, 2024]
- Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments - STAT - March 29th, 2024 [March 29th, 2024]
- Researchers identify viable vaccine targets for hepatitis C infections - News-Medical.Net - March 29th, 2024 [March 29th, 2024]
- Three research projects awarded funding from the Immunology Institute Pilot Project program - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Deal Watch: AbbVie Adds To Immunology Pipeline Through Deal With OSE - Scrip - February 29th, 2024 [February 29th, 2024]
- AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology ... - PR Newswire - February 29th, 2024 [February 29th, 2024]
- Integrating single-cell multi-omics and prior biological knowledge for a functional characterization of the immune system - Nature.com - February 29th, 2024 [February 29th, 2024]
- Renowned immunologist and four-decade UAB researcher Max Cooper, M.D., will deliver this year's Marx Lecture - University of Alabama at Birmingham - February 29th, 2024 [February 29th, 2024]
- Inactivation of TGF- signaling in CAR-T cells | Cellular & Molecular Immunology - Nature.com - February 29th, 2024 [February 29th, 2024]
- Babies use their immune system differently but efficiently | Cornell Chronicle - Cornell Chronicle - February 29th, 2024 [February 29th, 2024]
- Antibody reduces allergic reactions to multiple foods in NIH clinical trial - National Institutes of Health (NIH) (.gov) - February 29th, 2024 [February 29th, 2024]
- Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its ... - GlobeNewswire - February 21st, 2024 [February 21st, 2024]
- Theratechnologies announces publication in Frontiers in Immunology on TH1902 - TipRanks.com - TipRanks - February 21st, 2024 [February 21st, 2024]